» Articles » PMID: 38045926

Characterization of the Phage Lysis Protein MS2-L

Overview
Date 2023 Dec 4
PMID 38045926
Authors
Affiliations
Soon will be listed here.
Abstract

The peptide MS2-L represents toxins of the ssRNA Leviviridae phage family and consists of a predicted N-terminal soluble domain followed by a transmembrane domain. MS2-L mediates bacterial cell lysis through the formation of large lesions in the cell envelope, but further details of this mechanism as a prerequisite for applied bioengineering studies are lacking. The chaperone DnaJ is proposed to modulate MS2-L activity, whereas other cellular targets of MS2-L are unknown. Here, we provide a combined and overexpression approach to reveal molecular insights into MS2-L action and its interaction with DnaJ. Full-length MS2-L and truncated derivatives were synthesized cell-free and co-translationally inserted into nanodiscs or solubilized in detergent micelles. By native liquid bead ion desorption mass spectrometry, we demonstrate that MS2-L assembles into high oligomeric states after membrane insertion. Oligomerization is directed by the transmembrane domain and is impaired in detergent environments. Studies with truncated MS2-L derivatives provide evidence that the soluble domain acts as a modulator of oligomer formation. DnaJ strongly interacts with MS2-L in membranes as well as in detergent environments. However, this interaction affects neither the MS2-L membrane insertion efficiency nor its oligomerization in nanodisc membranes. In accordance with the in vitro data, the assembly of MS2-L derivatives into large membrane located clusters was monitored by overexpression of corresponding fusions with fluorescent monitors in cells. Analysis by cryo-electron microscopy indicates that lesion formation is initiated in the outer membrane, followed by disruption of the peptidoglycan layer and disintegration of the inner membrane. MS2-L forms oligomeric complexes similar to the related phage toxin ΦX174-E. The oligomeric interface of both peptides is located within their transmembrane domains. We propose a potential function of the higher-order assembly of small phage toxins in membrane disintegration and cell lysis.

Citing Articles

Circumventing the Impossible: Cell-Free Synthesis of Protein Toxins for Medical and Diagnostic Applications.

Woelbern A, Ramm F Int J Mol Sci. 2025; 25(24.

PMID: 39769056 PMC: 11675919. DOI: 10.3390/ijms252413293.


Lysis Physiology of Infected with ssRNA Phage PRR1.

Daugelavicius R, Daujotaite G, Bamford D Viruses. 2024; 16(4).

PMID: 38675985 PMC: 11054506. DOI: 10.3390/v16040645.


Physiological characterization of single-gene lysis proteins.

Antillon S, Bernhardt T, Chamakura K, Young R J Bacteriol. 2024; 206(3):e0038423.

PMID: 38426721 PMC: 10955853. DOI: 10.1128/jb.00384-23.

References
1.
Maratea D, Young K, Young R . Deletion and fusion analysis of the phage phi X174 lysis gene E. Gene. 1985; 40(1):39-46. DOI: 10.1016/0378-1119(85)90022-8. View

2.
Morgner N, Robinson C . Massign: an assignment strategy for maximizing information from the mass spectra of heterogeneous protein assemblies. Anal Chem. 2012; 84(6):2939-48. DOI: 10.1021/ac300056a. View

3.
Krishnan R S, Satheesan R, Puthumadathil N, Kumar K, Jayasree P, Mahendran K . Autonomously Assembled Synthetic Transmembrane Peptide Pore. J Am Chem Soc. 2019; 141(7):2949-2959. DOI: 10.1021/jacs.8b09973. View

4.
Tanaka S, Clemons Jr W . Minimal requirements for inhibition of MraY by lysis protein E from bacteriophage ΦX174. Mol Microbiol. 2012; 85(5):975-85. PMC: 3429702. DOI: 10.1111/j.1365-2958.2012.08153.x. View

5.
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M . Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006; 2:2006.0008. PMC: 1681482. DOI: 10.1038/msb4100050. View